Walgreens Form 4: RSUs Converted to $11.45 Cash Plus Divested Asset Rights
Rhea-AI Filing Summary
Tracey D. Brown, Executive Vice President and President, Walgreens Retail, filed a Form 4 reporting disposition of company common stock and related RSUs in connection with the Merger. On 08/28/2025 the reporting person disposed of 348,051 shares (including shares underlying restricted stock units), and as a result reports 0 shares beneficially owned following the transaction. Under the Merger Agreement, each share of Common Stock was converted into $11.45 in cash per share plus one divested asset proceed right, and each RSU was cancelled in exchange for the same per-share consideration. Payment for any RSUs that were unvested at the Effective Time remains subject to the reporting person’s continued employment and the prior vesting conditions.
Positive
- Contractual cash consideration of $11.45 per share provides immediate, specified liquidity to holders at the Effective Time
- RSUs converted under the Merger Agreement, ensuring consistent treatment of equity and alignment with the transaction terms
Negative
- Reporting person’s beneficial ownership is 0 following the conversion, removing an executive insider shareholding
- Unvested RSU payments remain conditional on continued employment and prior vesting terms, which could affect payout timing
Insights
TL;DR: Insider holdings reduced to zero due to merger consideration; unvested RSU payout remains subject to continued service.
The Form 4 documents a merger-driven conversion of equity and RSUs rather than an open-market sale. That distinction matters for governance readers because the disposition arises from contract terms in the Merger Agreement: each share converted into predefined consideration of $11.45 cash plus a divested asset proceed right. The reporting person’s immediate beneficial ownership drops to zero, while potential payments for unvested RSUs are contingent on continued employment and original vesting schedules, preserving standard executive retention mechanics post-transaction.
TL;DR: The transaction is a merger-related conversion of equity and RSUs into cash plus divestiture rights, consistent with the Merger Agreement.
The filing clarifies that all common shares and RSUs were converted at the Effective Time under the Merger Agreement dated March 6, 2025. The per-share treatment—$11.45 cash and a divested asset proceed right—is explicit, and RSUs that were unvested remain subject to original vesting and continued service conditions. This is a routine, contractually mandated post-closing treatment in acquisitions and is material to holders because it defines the economic outcome for equity stakeholders.
FAQ
What did Tracey D. Brown report on Form 4 for WBA?
Why were the shares and RSUs disposed of on 08/28/2025?
What did shareholders receive per share under the Merger Agreement?
Will unvested RSUs be paid out immediately?
Does the Form 4 indicate an open-market sale by the insider?